Table 9.
Dorsal CA1 | Baseline | 2′ME-CCPA | Ventral CA1 | Baseline | 2′ME-CCPA |
---|---|---|---|---|---|
Vm, mV | −68.5 ± 0.8 (n = 6) | −72.3 ± 0.9* (n = 6) | Vm, mV | −65.0 ± 0.9 (n = 6) | −65.3 ± 0.94 (n = 6) |
Rin, MΩ | 60.8 ± 3.8 (n = 6) | 50.2 ± 3.2* (n = 6) | Rin, MΩ | 75.2 ± 5.4 (n = 6) | 75.4 ± 6.0 (n = 6) |
Rin, MΩ, at −73 mV | 56.0 ± 3.3 (n = 6) | 50.5 ± 3.1* (n = 6) | Rin, MΩ, at −73 mV | 60.2 ± 3.6 (n = 5) | 60.6.±3.1 (n = 5) |
2′ME-CCPA, 2-chloro-2′-C-methyl-N-6-cyclopentyladenosine. Statistically significant (
P < 0.05, Student's paired t-test compared with baseline).